Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314541) titled 'A Phase Ia Study of KMY Tablets in Healthy Subjects' on Dec. 18, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).

Primary Sponsor: Lei Yunshang Group

Condition: Healthy Volunteers

Intervention: Drug: KMY Tablets

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: December 15, 2025

Target Sample Size: 120

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07314541

Published by HT Digital Content Services...